Insider Transactions in Q2 2021 at Athira Pharma, Inc. (ATHA)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2021
|
John M Fluke Jr |
BUY
Other acquisition or disposition
|
Direct |
1,000
+0.69%
|
-
|
|
Jun 15
2021
|
John M Fluke Jr |
SELL
Other acquisition or disposition
|
Indirect |
3,000
-44.57%
|
-
|
|
Jun 10
2021
|
Glenna Mileson Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,305
+6.56%
|
$6,305
$1.35 P/Share
|
|
Jun 08
2021
|
Kevin Church CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,152
+6.67%
|
$3,152
$1.04 P/Share
|
|
May 18
2021
|
Mark James Litton President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
867
+1.33%
|
$12,138
$14.45 P/Share
|
|
May 18
2021
|
Hans Moebius Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,055
+50.0%
|
$28,770
$14.45 P/Share
|
|
May 18
2021
|
Glenna Mileson Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,554
+1.83%
|
$21,756
$14.45 P/Share
|